Utilizing the same elements to differentiate between LN and other glomerular diseases, Kudose et al. achieved an AUC of 98% to distinguish anti-phospholipase A2 receptor (anti-PLA2R) positive membranous glomerulopathy from class V LN [18]. The gene discussed is PLA2R1; the disease is lobular neoplasia.